TickerFactsScreenerDevelopers

ADC Therapeutics SA (ADCT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2022: $326.44M2023: $278.60M2024: $250.87M2025: $261.34M$261.34M
2022Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$261.34M+4.2%
2024$250.87M-10.0%
2023$278.60M-14.7%
2022$326.44M—